* Liquidia Corp reported a quarterly adjusted loss of 30 cents per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of -24 cents. The mean expectation of ten analysts for the quarter was for a loss of 37 cents per share. Wall Street expected results to range from -44 cents to -31 cents per share.
* Revenue rose 20.9% to $4.45 million from a year ago; analysts expected $4.19 million.
* Liquidia Corp's reported EPS for the quarter was a loss of 30 cents.
* The company reported a quarterly loss of $23.16 million.
* Liquidia Corp shares had risen by 6.3% this quarter and lost 11.6% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by about 12.4% in the last three months.
* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the pharmaceuticals peer group is also "buy"
Wall Street's median 12-month price target for Liquidia Corp is $27.00 This summary was machine generated from LSEG data November 13 at 03:25 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.37 -0.30 Beat
Jun. 30 2024 -0.34 -0.37 Missed
Mar. 31 2024 -0.32 -0.54 Missed
Dec. 31 2023 -0.24 -0.42 Missed
Comments